Exploring the Metabolic Landscape of AML: From Haematopoietic Stem Cells to Myeloblasts and Leukaemic Stem Cells
Despite intensive chemotherapy regimens, up to 60% of adults with acute myeloid leukaemia (AML) will relapse and eventually succumb to their disease. Recent studies suggest that leukaemic stem cells (LSCs) drive AML relapse by residing in the bone marrow niche and adapting their metabolic profile. M...
Main Authors: | Yashar Mesbahi, Toby N. Trahair, Richard B. Lock, Patrick Connerty |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.807266/full |
Similar Items
-
Generation of Leukaemia-Derived Dendritic Cells (DC<sub>leu</sub>) to Improve Anti-Leukaemic Activity in AML: Selection of the Most Efficient Response Modifier Combinations
by: Christoph Schwepcke, et al.
Published: (2022-07-01) -
Long Non-coding RNAs: Major Regulators of Cell Stress in Cancer
by: Patrick Connerty, et al.
Published: (2020-03-01) -
Testicular leukaemic infiltration in relapsed acute lymphoblastic leukaemia: a case report
by: Abdul Qadir Qader, et al.
Published: (2024-01-01) -
Circulating Tumor DNA in Pediatric Cancer
by: Louise Doculara, et al.
Published: (2022-05-01) -
Ocular Manifestations of Leukaemia: A Cross-sectional Study from Tertiary Care Hospital of South Gujarat, India
by: Umeshaben Ishvarbhai Padvi, et al.
Published: (2024-04-01)